Georgios Chrysos

1.5k citations
35 papers · 1.1k · 1 hit paper · h-index 12

Impact in

    • COVID-19 Clinical Research Studies
    • HIV/AIDS Research and Interventions
    • SARS-CoV-2 and COVID-19 Research
  • Virology top 5%
    • HIV Research and Treatment

Papers in

    • HIV/AIDS Research and Interventions 10
    • COVID-19 Clinical Research Studies 7
    • HIV/AIDS drug development and treatment 2
    • HIV Research and Treatment 9

Georgios Chrysos

35 papers receiving 1.1k citations

Georgios Chrysos's Hit Papers

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 2021 · 431 citations
4310+1+3Years since publication100200300400

Peers

Georgios Chrysos
Comparison fields: 5 of 75
  • Infectious Diseases 538
  • Virology 106
  • Applied Microbiology and Biotechnology 42
  • Molecular Medicine 110
  • Epidemiology 177
Replace Chiara Tassan Din with:
Chiara Tassan Din Italy
Miguel Ángel López‐Ruz Spain
Elisabetta Grilli Italy
Frederick P. Duncanson United States
Marco Franzetti Italy
Vissaria Sakka Greece
Giulia Morsica Italy
Yukihiro Yoshimura Japan
Quanhathai Kaewpoowat United States
Jacques Jourdan France
Georgios Chrysos relative to Chiara Tassan Din Italy Chiara Tassan Din's profile →
Citations per field
00.5×2×3×3.9×
Chiara Tassan Din · 1×
Citations per year

Countries citing papers authored by Georgios Chrysos

Since Specialization
Citations

This map shows the geographic impact of Georgios Chrysos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgios Chrysos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgios Chrysos more than expected).

Fields of papers citing papers by Georgios Chrysos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgios Chrysos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgios Chrysos. The network helps show where Georgios Chrysos may publish in the future.

Co-authors

The 25 scholars most cited alongside Georgios Chrysos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Georgios Chrysos Line = papers co-authored together Georgios Chrysos links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
Hit paper breakdown →
2021431
2 2021138
3 2020101
4 201094
5 200765
6 200448
7 201731
8 202224
9 201922
10 202221
11 201814
12 200113
13 202212
14 201711
15 202211
16 201710
17 202410
18 202410
19 20179
20 20219

About Georgios Chrysos

Georgios Chrysos is a scholar working on Infectious Diseases, Virology, Applied Microbiology and Biotechnology, Molecular Medicine and Epidemiology, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (9 papers), COVID-19 Clinical Research Studies (7 papers), Antibiotic Use and Resistance (4 papers), Sepsis Diagnosis and Treatment (2 papers), HIV/AIDS drug development and treatment (2 papers), Antibiotic Resistance in Bacteria (2 papers) and HIV-related health complications and treatments (1 paper). The work is most often cited by research in Infectious Diseases (538 citations), Virology (106 citations), Applied Microbiology and Biotechnology (42 citations), Molecular Medicine (110 citations) and Epidemiology (177 citations). Georgios Chrysos has collaborated with scholars based in Greece, United Kingdom and France. Frequent co-authors include Olympia Zarkotou, Spyros Pournaras, Athanasios Tsakris, Katerina Themeli-Digalaki, Evangelia Voulgari, Athanassios Prekates, Helen Sambatakou, Anastasia Antoniadou, Giota Touloumi and Gkikas Magiorkinis. Their work appears in journals such as Viruses, PLoS ONE, European Journal of Clinical Microbiology & Infectious Diseases, AIDS and Sexually Transmitted Infections.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact